newsfilter
← Latest News
GlobeNewswire·

MapLight Therapeutics to Participate in Upcoming Investor Conference

  • MapLight Therapeutics (NASDAQ: MPLT) announced its management team will participate in the Morgan Stanley 24th Annual Global Healthcare Conference in New York, NY on Monday, September 14, 2026.
  • The company will present at the event & host one-on-one meetings with investors.
  • Live webcasts & archived recordings of the conference will be available on the "Events & Presentations" page of MapLight's investor website.
  • MapLight Therapeutics is a clinical-stage biopharmaceutical company focused on treating central nervous system disorders via circuit-specific pharmacotherapies.
  • The company was founded by leaders in psychiatry & neuroscience research to address the lack of therapies targeting neural circuits causally linked to disease.
  • Investor inquiries can be directed to investors@maplightrx.com, while media inquiries should go to media@maplightrx.com.